Brigham and Women's Hospital at IDWeek 2026
Oct 21–24, 2026 Washington, DC ~12k attendees Website
Brigham and Women's Hospital brings 22 presentations to IDWeek 2026 in Washington. Its program centres on shorter and narrower antibiotic courses, such as early de-escalation for neutropenic fever and shorter amoxicillin for childhood pneumonia, and on HIV care. It also brings low-cost tests for drug-resistant bacteria in resource-limited settings and genomic study of resistant Klebsiella in Peru.
| Organization | IDWeek 2026 Attendance |
|---|---|
Brigham and Women's Hospital Boston, MA | |
Talk Wed Oct 21 1:30pm–1:55pm Clinical ID Sciences Global and public healthHIV, sexually transmitted infections and viral hepatitis Talk Wed Oct 21 3:45pm–5:30pm Industry Wed Oct 21 7:00pm–8:30pm A Switch in Time: State-of-the-Art Strategies for ART Modification in People with Virologically Suppressed HIV HIV, sexually transmitted infections and viral hepatitisAntimicrobials, resistance and stewardship Poster Thu Oct 22 12:15pm–1:30pm A Rapid, Inexpensive Diagnostic for Bacterial Pathogen and Resistance Detection in Resource-Limited Settings Poster Thu Oct 22 12:15pm–1:30pm Evaluation of Model-Informed Precision Dosing (MIPD) for Posaconazole Poster Thu Oct 22 12:15pm–1:30pm Five vs Ten Days of Amoxicillin for Pediatric Community Acquired Pneumonia in the Emergency Department Poster Thu Oct 22 12:15pm–1:30pm Genomic and epigenomic characterization of carbapenem-resistant Klebsiella pneumoniae in Peru: high sequence type diversity and evidence for horizontal methyltransferase transfer Poster Thu Oct 22 12:15pm–1:30pm Low-Cost Approaches for Detecting Antimicrobial Resistance in Bacterial Infections in Resource-Limited Settings: A Scoping Review Session Thu Oct 22 3:15pm–4:30pm Controversies in Pneumonia Diagnosis and Treatment Respiratory infections and COVID-19Antimicrobials, resistance and stewardship Industry Thu Oct 22 6:30pm–8:30pm Optimizing Outcomes with LAI PrEP and ART: Advanced Clinical Decision Making in HIV Care - An Interactive Showcase™ HIV, sexually transmitted infections and viral hepatitisAntimicrobials, resistance and stewardship Session Fri Oct 23 10:30am–11:45am "You Want to Put the Antibiotic WHERE?!" (Part 2) Exploring Off-Label Routes of Administration and Novel Delivery Methods for Challenging Infections Global and public healthHIV, sexually transmitted infections and viral hepatitisTransplant and immunocompromised hostsAntimicrobials, resistance and stewardship Talk Fri Oct 23 11:20am–11:45am Is Intravesical Instillation of Antimicrobials Useful ? Global and public healthHIV, sexually transmitted infections and viral hepatitisTransplant and immunocompromised hostsAntimicrobials, resistance and stewardship Poster Fri Oct 23 12:15pm–1:30pm Infectious complications in acute myeloid leukemia (AML) patients receiving azacitidine-venetoclax versus intensive induction chemotherapy on the PARADIGM randomized clinical trial Session Fri Oct 23 1:45pm–3:00pm When IV Is Not an Option: Ethics, Economics and Real-Life Questions in Treating Infections in People Who Use Drugs Antimicrobials, resistance and stewardship Session Sat Oct 24 12:00pm–1:00pm Poster Sat Oct 24 12:15pm–1:30pm Distinct Patient Profiles Among Hospitalized Patients with Complicated Urinary Tract Infection Treated with Intravenous Carbapenems: A Machine Learning Approach Poster Sat Oct 24 12:15pm–1:30pm END (Early Neutropenic Fever De-escalation of) Antibiotics Study: an open-label, randomized, controlled phase 4 trial Poster Sat Oct 24 12:15pm–1:30pm From Diagnosis to Follow-Up: Evaluating Gaps in the Syphilis Care Cascade Among Cisgender Women Poster Sat Oct 24 12:15pm–1:30pm Rule-based Classification to Determine Outpatient-Eligible Versus Inpatient-Required Among Patients Hospitalized for Complicated Urinary Tract Infection Poster Sat Oct 24 12:15pm–1:30pm The Association of Body Mass Index and HIV Acquisition in Men Who Have Sex with Men: A Secondary Analysis of the HVTN 505 Trial Talk Sat Oct 24 12:30pm–12:35pm END (Early Neutropenic Fever De-escalation of) Antibiotics Study: an open-label, randomized, controlled phase 4 trial Antimicrobials, resistance and stewardshipTransplant and immunocompromised hosts Session Sat Oct 24 1:45pm–3:00pm 2026 Case-Based Gu(ID)elines: Aspergillosis, Immunomodulators and Staphylococcus aureus Bacteremia Transplant and immunocompromised hostsAntimicrobials, resistance and stewardship |
Instantly find 20 buyers from Brigham and Women's Hospital
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction